Hims & Hers Launches Peptides Despite Efficacy Risks

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.


Comment
Show comments Hide Comments


Related Articles